Evaluation of isotonitazene by Blanckaert et al. demonstrated that isotonitazene is a robust opioid based upon its high potency and efficacy (4). The authors declare no conflict of interest. The funders had no position in the design with the research; in the gathering, analyses, or interpretation of information; inside the https://cryptoscamrecovery01111.onesmablog.com/the-smart-trick-of-metonitazene-for-sale-in-copyright-that-nobody-is-discussing-70263077